*By Michael Teich* Brexit could be a major bump in the road for Aston Martin if it disrupts trade with the automaker's European partners, said the company's CMO Simon Sproule. "The biggest threat to us of Brexit is non-tariff barriers, because if you end up getting import duties on Astons going into Europe, then you're going to get import duties on Ferraris coming into the UK. So it's a zero-sum game," Sproule said Tuesday in an interview on Cheddar. The Brexit withdrawal process began March 29, 2017 after a countrywide vote, and the UK is set to depart from the European Union on March 29, 2019. A new report from the Federation of German Industries said a "hard Brexit" ー meaning in the absence of a deal between the EU and the UK ー could cause exports to Britain from the rest of the EU to drop by as much as [57 percent](https://www.dw.com/en/german-industry-warns-against-hard-brexit/av-45818058). That kind of trade disturbance would not be good for business, Sproule said. "What we're lobbying the government most strongly about is to ensure the free flow of parts and obviously completed vehicles," he added. Aston Martin ($AML.L) is the latest luxury automaker to make its market debut. Despite a rough start on the London Stock Exchange since its Oct. 3 IPO ー shares are down 16 percent since ー Sproule said patient investors will benefit from the company's future growth. "The IPO was effectively a marker in our evolution," he said. "People that have been buying into us are buying in for the long term. They buy into the equity story, they buy into the future potential of Aston Martin." For full interview [click here](https://cheddar.com/videos/aston-martin-cmo-we-have-no-interest-in-making-cheaper-cars).

Share:
More In Culture
The State of Lactation Support in the U.S.
Sarah Kellogg Neff, CEO of The Lactation Network, joins ChedHER to discuss how they are expanding access to lactation support for families nationwide, and some of the struggles new families face during the fourth trimester.
American Gaming Association Says 45 Million Americans to Wager $3.1 Billion on March Madness
March Nadness is officially underway, and betting on this year's tournament has the potential to reach record levels. About 45 million Americans are expected to wager a total of $3.1 billion on just the men's tournament alone, according to a new survey from the American Gaming Association. Prince Grimes, Senior Writer for USA Today's sports betting media property, BetFTW, joins Cheddar News' Closing Bell to discuss how betting could play into this year's tournament and other storylines surrounding March Madness.
Medical Cannabis Company Akanda Sees Stock Surge in March's First IPO
Medical cannabis company Akanda went public this week in what was the first traditional IPO of the month. Shares jumped about 163% in the stock's first day of trading. The London-based company says it hopes to supply medical cannabis products to wholesalers in international markets. Tej Virk, CEO of Akanda, joins Cheddar News' Closing Bell to discuss.
Akeneo CEO on $135 Million Fundraise to Redefine Product Management
Software company Akeneo CEO Fred De Gombert joined Closing Bell to discuss its recently closed Series D funding round raising $135 million in its quest to redefine product information management. De Gombert said the company is set out to improve the product information category by harnessing the power of data, which comes at a time where customer behavior has shifted in the pandemic era. "We are more and more demanding as consumers when we are shopping online or even offline. We are looking for more and more information," De Gombert said.
Colossal CEO Says Its About Saving Biodiversity, Not Just Extinct Woolly Mammoth
Bioscience and genetic engineering company, Colossal, raised $60 million in a Series A funding round. Colossal is focused on developing new technologies and genetic tools to restore extinct species, and protect critically endangered species. One of the startup's long-term goals is to resurrect the woolly mammoth, and return it back to the arctic. Colossal also says it is developing technology that expands beyond animals, and has the potential to advance human health. Ben Lamm, co-founder and CEO of Colossal, joins Cheddar News' Closing Bell to discuss.
Load More